Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 23,401–23,425 of 27,380 studies, newest first · page 937 of 1096.

November 2005 25

  1. 2005-11-29

    Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study

    ✓ Peer-reviewed Vascular contributions Brain : a journal of neurology

    Key finding: Larger venular diameters were, however, associated with a marked progression of cerebral small vessel disease. +1 more finding

  2. 2005-11-23

    Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma

    ✓ Peer-reviewed Drug development Cancer letters

    Key finding: We have previously demonstrated an increase of APP expression in oral squamous cell carcinoma (OSCC) and related OSCC cell lines. +3 more findings

  3. 2005-11-23

    Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease

    ✓ Peer-reviewed Hippocampus size on brain scans Journal of neurology, neurosurgery, and psychiatry

    Key finding: Hippocampal atrophy is not only a characteristic of Alzheimer's disease but also occurs in FTLD. +4 more findings

  4. 2005-11-23

    Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease

    ✓ Peer-reviewed Brain tissue and pathology Journal of neurochemistry

    Key finding: Advancements in molecular, cellular, and animal model studies have revealed that the formation of amyloid beta (Abeta) and other derivatives of the amyloid precursor protein (APP) are key factors in cellular changes in the AD brain, including the generation of free radicals, oxidative damage, and inflammation. +3 more findings

  5. 2005-11-16

    Epidemiology and risk factors of dementia

    ✓ Peer-reviewed Risk factors Journal of Neurology Neurosurgery & Psychiatry

    Key finding: PREVALENCEPrevalence is defined as the proportion of a population that has disease at a specific point in time.

  6. 2005-11-15

    Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease

    ✓ Peer-reviewed Risk genes beyond APOE PLoS medicine

    Key finding: The proteases (secretases) that cleave amyloid-beta (Abeta) peptide from the amyloid precursor protein (APP) have been the focus of considerable investigation in the development of treatments for Alzheimer disease. +3 more findings

  7. 2005-11-09

    Visual dysfunction in Parkinson disease without dementia

    ✓ Peer-reviewed Digital health tools Neurology

    Key finding: Patients with mild to moderate Parkinson disease showed impaired visual perception and cognition compared with elderly control subjects. +1 more finding

  8. 2005-11-09

    Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment

    ✓ Peer-reviewed Genetics Neurobiology of aging

    Key finding: Individuals with eAD had significantly fewer synapses than the other two diagnostic groups. +4 more findings

  9. 2005-11-08

    Do‐Not‐Resuscitate and Do‐Not‐Hospitalize Directives of Persons Admitted to Skilled Nursing Facilities Under the Medicare Benefit

    ✓ Peer-reviewed Risk factors Journal of the American Geriatrics Society

    Key finding: Thirty-two percent of residents had DNR directives, whereas less than 2% had DNH directives. +4 more findings

  10. 2005-11-08

    Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

    ✓ Peer-reviewed Getting a diagnosis Diabetologia

    Key finding: Compared to people without diabetes, people with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline. +1 more finding

  11. 2005-11-07

    Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent

    ✓ Peer-reviewed Risk genes beyond APOE Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Potent, reversible, and brain-targeted BChE inhibitors (cymserine analogs) were developed based on binding domain structures to help elucidate the role of this enzyme in the central nervous system. +3 more findings

  12. 2005-11-04

    Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD

    ✓ Peer-reviewed Genetics Neurobiology of aging

    Key finding: In AD hippocampus, peptidyl prolyl cis-trans isomerase, phosphoglycerate mutase 1, ubiquitin carboxyl terminal hydrolase 1, dihydropyrimidinase related protein-2 (DRP-2), carbonic anhydrase II, triose phosphate isomerase, alpha-enolase, and gamma-SNAP were identified as significantly oxidized protein with reduced enzyme activities relative to control hippocampus. +1 more finding

  13. 2005-11-03

    Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia

    ✓ Peer-reviewed Long-term cohort studies Stroke

    Key finding: Vascular and inflammatory factors may play an important role in the pathogenesis of dementia. +3 more findings

  14. 2005-11-03
  15. 2005-11-01

    Vulnerable populations at risk of potentially avoidable hospitalizations: the case of nursing home residents with Alzheimer's disease

    ✓ Peer-reviewed Digital health tools American journal of Alzheimer's disease and other dementias

    Key finding: The findings suggest that nursing home residents with ADRD are more likely to be hospitalized for certain ACS conditions, including gastroenteritis and kidney/ urinary tract infections. +1 more finding

  16. 2005-11-01

    Curcumin: getting back to the roots

    ✓ Peer-reviewed Costs and economics Annals of the New York Academy of Sciences

    Key finding: Modern science has revealed that curcumin mediates its effects by modulation of several important molecular targets, including transcription factors (e.g., NF-kappaB, AP-1, Egr-1, beta-catenin, and PPAR-gamma), enzymes (e.g., COX2, 5-LOX, iNOS, and hemeoxygenase-1), cell cycle proteins (e.g., cyclin D1 and p21), cytokines (e.g., TNF, IL-1, IL-6, and chemokines), receptors (e.g., EGFR and HER2), and cell surface adhesion molecules.

  17. 2005-11-01

    The interplay of neurotransmitters in Alzheimer's disease

    ✓ Peer-reviewed Treatments CNS spectrums

    Key finding: The sustained low-level activation of NMDA receptors, which are pivotal in learning and memory, may result from deficiencies in glutamate reuptake by astroglial cells in the synaptic cleft. +1 more finding

  18. 2005-11-01

    Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain

    ✓ Peer-reviewed Brain scans and imaging The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: Unexpectedly, we saw no significant retention of PIB in this model even at 12 months of age when amyloid deposition in the PS1/APP mouse typically exceeds that seen in AD. +1 more finding

  19. 2005-11-01

    Benefits of rivastigmine on attention in dementia associated with Parkinson disease

    ✓ Peer-reviewed Cognitive tests and assessment Neurology

    Key finding: In a 24-week, randomized, double-blind, placebo-controlled, multicenter study of rivastigmine, 487 patients with dementia associated with Parkinson disease underwent assessment of attention on the Cognitive Drug Research computerized cognitive assessment system before dosing and 16 and 24 weeks later. +1 more finding

  20. 2005-11-01

    Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory

    ✓ Peer-reviewed Hippocampus size on brain scans Archives of general psychiatry

    Key finding: Specific alleles of the DISC1 and TRAX genes on 1q42 appear to contribute to genetic risk for schizophrenia through disruptive effects on the structure and function of the prefrontal cortex, medial temporal lobe, and other brain regions. +1 more finding

  21. 2005-11-01

    Neuropathology of dementia in Parkinson's disease: a prospective, community-based study

    ✓ Peer-reviewed Clinical safety Annals of neurology

    Key finding: The Lewy body score and Braak and Braak stage were significantly associated with the rate of cognitive decline, but only the Lewy body score was associated with the rate of cognitive decline in the univariate analyses. +1 more finding

  22. 2005-11-01

    Progressive neurodegeneration in C. elegans model of tauopathy

    ✓ Peer-reviewed Disease mechanisms Neurobiology of disease

    Key finding: Whereas the worm expressing wild-type tau showed a small decrease in the touch response across the lifespan, the worm expressing mutant tau displayed a large and progressive decrease. +4 more findings

  23. 2005-11-01

    Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia

    ✓ Peer-reviewed Disease mechanisms Archives of neurology

    Key finding: Patients with Alzheimer disease have reduced levels of sRAGE in plasma compared with patients with vascular dementia and controls. +1 more finding

  24. 2005-11-01

    The Alzheimer's Disease Neuroimaging Initiative

    ✓ Peer-reviewed Long-term cohort studies Neuroimaging Clinics of North America

    This text describes the Alzheimer's Disease Neuroimaging Initiative, which addresses the growing incidence and socioeconomic impact of Alzheimer's disease as life expectancy increases.

  25. 2005-11-01

    Depression, Dementia, or Pseudodementia?

    ✓ Peer-reviewed Risk factors CNS Spectrums

    Key finding: Her husband indicated that she rarely drinks alcohol.

Browse the library by subject, with the full score breakdown →